# OnCo record paper-bolt-sonidegib-migden-lancet-oncol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bolt-sonidegib-migden-lancet-oncol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bolt-sonidegib-migden-lancet-oncol-2015" ;
  schema:name "BOLT: two doses of sonidegib in locally advanced or metastatic basal cell carcinoma"@en ;
  schema:description "Sonidegib, a second hedgehog inhibitor, shrank tumours in about 40 percent of patients with locally advanced basal cell carcinoma at the lower 200 mg dose with fewer side effects than the higher dose, and was approved as an alternative to vismodegib."@en ;
  schema:url <https://onco.cc/key-papers/paper-bolt-sonidegib-migden-lancet-oncol-2015/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)70100-2>, <https://pubmed.ncbi.nlm.nih.gov/25981810/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(15)70100-2> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Migden MR, Guminski A, Gutzmer R, et al." ;
  onco:cancers <https://onco.cc/cancers/locally-advanced-bcc/> ;
  onco:drugs <https://onco.cc/drugs/sonidegib/> ;
  onco:trials <https://onco.cc/trials/bolt/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .